表紙:臓器移植・組織移植と代替手段
市場調査レポート
商品コード
977431

臓器移植・組織移植と代替手段

Organ and Tissue Transplantation and Alternatives

出版日: | 発行: BCC Research | ページ情報: 英文 207 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.72円
臓器移植・組織移植と代替手段
出版日: 2020年12月10日
発行: BCC Research
ページ情報: 英文 207 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臓器移植・組織移植と代替手段市場は、2020年の899億米ドルから、2024年までに1,203億米ドルに達し、2019年~2024年のCAGRで7.4%の成長が予測されています。代替技術セグメントは、2020年の221億米ドルから、2024年には308億米ドルに達し、2019年~2024年のCAGRで8.6%の成長が予測されています。組織製品セグメントは、2020年の384億米ドルから、2024年には542億米ドルに達し、2019年~2024年のCAGRで8.9%の成長が予測されています。

当レポートでは、世界の臓器移植・組織移植と代替手段市場について調査分析し、市場概要、市場力学、市場の内訳、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 市場・技術の背景

  • 治療費用
  • 固形臓器の保存
  • 免疫抑制
  • 臓器移植の代替手段
  • 臓器移植・組織移植の技術とその代替手段の動向
  • 3D組織アセンブリ
  • 組織再生のナノテクノロジー
  • イノベーション:小企業別

第4章 市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第5章 市場の内訳:製品・デバイス別

  • 臓器移植・組織移植と代替手段の世界市場
  • 代替技術
  • 市場規模と予測
  • 心臓移植の代替手段
  • 手術
  • 機械的
  • 完全置換型人工心臓
  • 補助人工心臓(VAD)
  • 設計の世代
  • 整形外科の代替手段
  • 組織製品
  • 市場規模と予測
  • 免疫抑制剤
  • 市場規模と予測
  • 固形臓器保存溶液
  • 市場規模と予測
  • 開発中の保存溶液
  • 組織適合検査
  • 市場規模と予測

第6章 市場の内訳:地域別

  • 臓器移植・組織移植と代替手段の世界市場
  • 北米
  • 米国
  • カナダ
  • メキシコ
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他の欧州
  • アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア・ニュージーランド
  • その他のアジア太平洋地域
  • その他の地域
  • 市場分析
  • ブラジル
  • 南アフリカ
  • その他の諸国

第7章 COVID-19の影響

  • イントロダクション
  • 腎臓移植プログラムへの影響
  • 製薬企業への影響
  • ドナー検査
  • 移植レシピエントにおけるCOVID-19
  • レシピエントの感染リスクを最小限に抑える
  • 今後の見通し

第8章 ドナープロセスの概要

  • イントロダクション
  • ブラックマーケットドナー
  • 移植プロセス
  • 米国における固形臓器移植の費用

第9章 規制と償還

  • 米国の規制
  • ヒト組織に関する米国連邦の規制
  • 米国における規制の歴史
  • 米国外の規制
  • 米国の償還
  • 臓器取得費用
  • 病院費用の償還
  • 医師サービスの償還
  • 米国における免疫抑制剤の償還
  • 米国外の償還
  • EU諸国の治療

第10章 競合情勢

  • 世界の企業ランキング分析
  • 合併と買収
  • 契約・着手・提携・パートナーシップ

第11章 企業プロファイル

  • ABIOMED INC.
  • ABBVIE INC.
  • AMGEN INC.
  • ASTRAZENECA
  • BAYER AG
  • BRISTOL-MYERS SQUIBB
  • CAREDX INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • JOHNSON & JOHNSON
  • MYLAN N.V.
  • NOVARTIS AG
  • PFIZER INC.
  • TRANSMEDICS INC.
  • VERTEX PHARMACEUTICALS INC.
  • XVIVO PERFUSION

第12章 付録:略語

図表

List of Tables

  • Summary Table A : Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
  • Summary Table B : Global Market for Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
  • Table 1 : MiMedx: Patent Portfolio
  • Table 2 : Product Launches in Transplant Diagnostics, 2012-2016
  • Table 3 : Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
  • Table 4 : Global Market for Alternative Technologies in Organ and Tissue Transplantation and Alternatives, Through 2024
  • Table 5 : Selected Global Commercial Opportunities for New Orthopedic Devices in the Future
  • Table 6 : Indications for Bioartificial Liver Transplantation
  • Table 7 : Global Market for Alternative Technologies in the Organ and Tissue Transplantation and Alternatives Market, by Region, Through 2024
  • Table 8 : Global Market for Tissue Products in the Organ and Tissue Transplantation and Alternatives Market, Through 2024
  • Table 9 : Cartilage and Soft Tissue Biologics and Biomaterials
  • Table 10 : Global Market of Tissue Products in Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
  • Table 11 : Therapeutic Effects of Immunosuppressants
  • Table 12 : Global Market for Immunosuppressants in the Organ and Tissue Transplantation and Alternatives Market, Through 2024
  • Table 13 : Immunosuppressants, by Drug Class, Generic Name, Brand Name, and Manufacturer
  • Table 14 : Global Market of Immunosuppressants in the Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
  • Table 15 : Cold Ischemia Time for Transplanted Organs
  • Table 16 : Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, Through 2024
  • Table 17 : Optimal Preservation Solution Design
  • Table 18 : Major Organ Preservation Solutions
  • Table 19 : Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
  • Table 20 : Tissue Typing Technologies
  • Table 21 : Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, Through 2024
  • Table 22 : Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
  • Table 23 : Global Market for Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
  • Table 24 : North American Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
  • Table 25 : North American Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
  • Table 26 : European Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
  • Table 27 : European Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
  • Table 28 : Transplant Numbers in Germany, 2013-2019
  • Table 29 : Statistics for Cost of Bone Damage Repair and Related Disorders in Europe
  • Table 30 : Asia-Pacific Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
  • Table 31 : Asia-Pacific Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
  • Table 32 : Types of Organ Rejection After Transplant Procedures
  • Table 33 : Organ Transplantation Rates in Southeast Asian Countries, 2011-2014
  • Table 34 : Rest of the World Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
  • Table 35 : Registered Liver Transplantations (LT)/Kidney Transplantation in Middle East Countries, 2017
  • Table 36 : Rest of the World Market for Organ and Tissue Transplantation and Alternatives, by Country, Through 2024
  • Table 37 : Communicable and Noncommunicable Diseases Leading to Mortality in Brazil, 2018
  • Table 38 : Number of Organ Transplant Procedures in Brazil, by Type of Organ, 2015
  • Table 39 : Number of Organ Transplant Procedures in Turkey, by Type of Organ, 2019-2020
  • Table 40 : Pharmaceutical Company Efforts to Tackle COVID-19
  • Table 41 : U.S. Organ/Tissue Transplants: Total Estimated Transplants and Estimated Billed Charges, 2019
  • Table 42 : Immunosuppressive Drugs Currently Covered, by Medicare*
  • Table 43 : Overview of Medicare Immunosuppressive Drug Coverage
  • Table 44 : Selected Transplant Industry Acquisitions, 2010-Early 2015
  • Table 45 : Abiomed Inc: Product Portfolio
  • Table 46 : AbbVie: Product Portfolio
  • Table 47 : Amgen Inc.: Product Portfolio
  • Table 48 : AstraZeneca: Product Portfolio
  • Table 49 : Bayer AG: Product Portfolio
  • Table 50 : Bristol-Myers Squibb: Product Portfolio
  • Table 51 : CareDx Inc.: Product Portfolio
  • Table 52 : F. Hoffmann-La Roche & Co.: Product Portfolio
  • Table 53 : Johnson & Johnson: Immunosuppressants Product Portfolio
  • Table 54 : Mylan N.V.: Product Portfolio
  • Table 55 : Novartis AG: Product Portfolio
  • Table 56 : Pfizer Inc.: Product Portfolio
  • Table 57 : Pfizer Inc.: Pipeline Product Portfolio
  • Table 58 : Transmedics Inc.: Product Portfolio
  • Table 59 : Vertex Pharmaceuticals Inc.: Product Portfolio
  • Table 60 : XVIVO Perfusion: Product Portfolio
  • Table 61 : Acronyms Used in This Report

List of Figures

  • Summary Figure A : Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2018-2024
  • Summary Figure B : Global Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
  • Summary Figure C : Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
  • Summary Figure D : Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
  • Summary Figure E : Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
  • Figure 1 : Nanotechnology and Tissue Regeneration
  • Figure 2 : Number of Elderly (≥ 65 Years) Receiving Kidney Transplantation in the U.S., 2014-2018
  • Figure 3 : Number of Diabetes Patients Globally (20 to 79 Years of Age), 2000-2045
  • Figure 4 : Waiting List for Organs in the U.S., by Type of Organ, September 2020
  • Figure 5 : Number of Kidney Transplants, by Country, 2015
  • Figure 6 : Patients on Waiting List vs. Transplant Performed in the U.S., by Organ, 2019
  • Figure 7 : Global Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
  • Figure 8 : Global Market for Alternative Technologies in Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 9 : Global Market Shares of Alternative Technologies in Organ and Tissue Transplantation and Alternatives, 2019
  • Figure 10 : Global Market Shares of Orthopedic Alternatives in Organ and Tissue Transplantation and Alternatives, 2019
  • Figure 11 : Global Market for Alternative Technologies in the Organ and Tissue Transplantation and Alternatives Market, by Region, 2018-2024
  • Figure 12 : Global Market for Tissue Products in the Organ and Tissue Transplantation and Alternatives Market, 2018-2024
  • Figure 13 : Global Market Shares for Tissue Products in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 14 : Global Market Shares for Peripheral Blood Stem Cells, Cord Blood, Bone Marrow in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 15 : Global Market Shares for Orthobiologics (Bone Allografts, Machined Bone, DBM) in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 16 : Global Market of Tissue Products in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
  • Figure 17 : Global Market for Immunosuppressants in the Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 18 : Global Market Shares for Immunosuppressants in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 19 : Global Market Shares for Calcineurin Inhibitors in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 20 : Global Market Shares for Anti-proliferative Agents in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 21 : Global Market Shares for m-TOR Inhibitors in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 22 : Global Market Shares for Polyclonal Antibodies in the Organ and Tissue Transplantation and Alternatives Market, 2019
  • Figure 23 : Global Market of Immunosuppressants in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
  • Figure 24 : Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 25 : Global Market Shares for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, 2019
  • Figure 26 : Global Market for Solid Organ Preservation Solutions in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
  • Figure 27 : Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 28 : Global Market for Tissue Typing in Organ and Tissue Transplantation and Alternatives, by Region, 2018-2024
  • Figure 29 : Global Market Shares of Organ and Tissue Transplantation and Alternatives, by Region, 2019
  • Figure 30 : North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
  • Figure 31 : North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Devices, 2019
  • Figure 32 : North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
  • Figure 33 : North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
  • Figure 34 : North American Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
  • Figure 35 : North American Market Shares for Organ and Tissue Transplantation and Alternatives, by Country, 2019
  • Figure 36 : United States Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 37 : Canadian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 38 : Mexican Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 39 : European Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
  • Figure 40 : European Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
  • Figure 41 : European Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
  • Figure 42 : European Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
  • Figure 43 : European Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
  • Figure 44 : European Market Shares of Organ and Tissue Transplantation and Alternatives, by Country, 2019
  • Figure 45 : German Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 46 : French Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 47 : U.K. Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 48 : Italian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 49 : Spainish Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 50 : Rest of Europe Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 51 : Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2019
  • Figure 52 : Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
  • Figure 53 : Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
  • Figure 54 : Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
  • Figure 55 : Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
  • Figure 56 : Asia-Pacific Market Shares of Organ and Tissue Transplantation and Alternatives, by Country, 2019
  • Figure 57 : Japanese Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 58 : Chinese Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 59 : Indian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 60 : Australia and New Zealand's Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 61 : Number of Organ Donations in Australia, by Type of Donor, 2015
  • Figure 62 : Rest of Asia-Pacific Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 63 : Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Products & Devices, 2019
  • Figure 64 : Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
  • Figure 65 : Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
  • Figure 66 : Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
  • Figure 67 : Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
  • Figure 68 : Rest of the World Market Shares of Organ and Tissue Transplantation and Alternatives, by Country, 2019
  • Figure 69 : Brazilian Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 70 : South African Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 71 : Rest of the World Countries Market for Organ and Tissue Transplantation and Alternatives, 2018-2024
  • Figure 72 : Steep Reduction in Organ Transplantation Seen During COVID-19
  • Figure 73 : Global Market Ranking in the Organ and Tissue Transplantation and Alternatives Market, by Pharmaceutical Company, 2019
  • Figure 74 : Global Market Ranking of Organ and Tissue Transplantation and Alternatives, by Diagnostic and Alternatives in the Organ Manufacturing Industry, 2019
  • Figure 75 : Abiomed Inc.: Annual Revenue, 2016-2020
  • Figure 76 : Abiomed Inc.: Revenue Shares for R&D, by Impella Devices, 2016-2020
  • Figure 77 : AbbVie: Annual Revenue, 2016-2019
  • Figure 78 : AbbVie: Revenue Shares, by Region/Country, 2019
  • Figure 79 : AbbVie: Revenue Shares, by Business Unit, 2019
  • Figure 80 : Amgen Inc.: Annual Revenue, 2016-2019
  • Figure 81 : Amgen Inc.: Revenue Shares, by Region/Country, 2019
  • Figure 82 : Amgen Inc.: Revenue Shares, by Products, 2019
  • Figure 83 : AstraZeneca: Annual Revenue, 2016-2019
  • Figure 84 : AstraZeneca: Revenue Shares, by Region/Country, 2019
  • Figure 85 : AstraZeneca: Revenue Shares, by Business Unit, 2019
  • Figure 86 : Bayer AG: Annual Revenue, 2016-2019
  • Figure 87 : Bayer AG: Revenue Shares, by Region, 2019
  • Figure 88 : Bayer AG: Revenue Shares, by Business Unit, 2019
  • Figure 89 : Bristol-Myers Squibb: Annual Revenue, 2016-2019
  • Figure 90 : Bristol-Myers Squibb: Revenue Shares, by Region/Country, 2019
  • Figure 91 : Bristol-Myers Squibb: Revenue Shares, by Brands, 2019
  • Figure 92 : CareDx Inc.: Annual Revenue, 2016-2019
  • Figure 93 : CareDx Inc.: Revenue Shares in Pharmaceutical Segment, by Region/Country, 2019
  • Figure 94 : CareDx Inc.: Revenue Shares, by Business Segment, 2019
  • Figure 95 : F. Hoffmann-La Roche & Co.: Annual Revenue, 2016-2019
  • Figure 96 : F. Hoffmann-La Roche & Co.: Revenue Shares in Pharmaceutical Segment, by Region/Country, 2019
  • Figure 97 : F. Hoffmann-La Roche & Co.: Revenue Shares, by Business Segment, 2019
  • Figure 98 : Johnson & Johnson: Annual Revenue, 2016-2019
  • Figure 99 : Johnson & Johnson: Revenue Shares, by Region/Country, 2019
  • Figure 100 : Johnson & Johnson: Revenue Shares, by Business Unit, 2019
  • Figure 101 : Mylan N.V.: Annual Revenue, 2016-2019
  • Figure 102 : Mylan N.V.: Revenue Shares, by Region, 2019
  • Figure 103 : Mylan N.V.: Revenue Shares, by Business Unit, 2019
  • Figure 104 : Novartis AG.: Annual Revenue, 2015-2019
  • Figure 105 : Novartis AG: Revenue Shares, by Region/Country, 2019
  • Figure 106 : Novartis AG: Revenue Shares, by Business Segment, 2019
  • Figure 107 : Pfizer Inc.: Annual Revenue, 2016-2019
  • Figure 108 : Pfizer Inc.: Revenue Shares, by Region/Country, 2019
  • Figure 109 : Pfizer Inc.: Revenue Shares, by Business Segment, 2019
  • Figure 110 : Transmedics Inc.: Annual Revenue, 2018 and 2019
  • Figure 111 : Transmedics Inc.: Revenue Shares, by OCS Product, 2019
  • Figure 112 : Transmedics Inc.: Revenue Shares, by Region/Country, 2019
  • Figure 113 : Vertex Pharmaceuticals Inc.: Annual Revenue, 2016-2019
  • Figure 114 : Vertex Pharmaceuticals Inc.: Research and Development Expense, 2017-2019
  • Figure 115 : Vertex Pharmaceuticals Inc.: Revenue Shares, by Business Segment, 2019
  • Figure 116 : XVIVO Perfusion: Annual Revenue, 2018 and 2019
  • Figure 117 : XVIVO Perfusion: Revenue Shares, by Region, 2019
目次
Product Code: HLC012G

Highlights:

The global organ and tissue transplantation and alternatives market should reach $120.3 billion by 2024 from $89.9 billion in 2020 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2019 to 2024.

The alternative technologies segment of the global organ and tissue transplantation and alternatives market is expected to grow from $22.1 billion in 2020 to $30.8 billion in 2024 at a CAGR of 8.6% for the forecast period of 2019 to 2024.

The tissue products segment of the global organ and tissue transplantation and alternatives market is expected to grow from $38.4 billion in 2020 to $54.2 billion in 2024 at a CAGR of 8.9% for the forecast period of 2019 to 2024.

Report Scope:

This report offers forecasts, by product segment, from 2018 through 2024, including supporting analyses for projections. Product segments covered consist of the solid organ (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation (e.g., bone, skin, cornea, heart valve) markets, along with the pharmaceuticals that accompany each market.

Also included are experimental xenografts and artificial organs; tissue transplants; and cell transplants (e.g., bone marrow, cord blood, peripheral blood, islet cell). The report touches on the use of fetal cells, stem cells and altered cancer cells.

The arrangement of this report offers an overview of the key elements in the transplantation process: tissue typing, procurement and preservation, immunosuppressants for solid organ and tissue transplants, and postoperative monitoring. International markets are discussed, and information is provided on industry structure and the regulatory environment.

Within each section are discussions of commercialization opportunities for each segment of the market. New or emerging devices, techniques and pharmaceuticals are highlighted.

Profiles of leading companies involved with solid organ transplantation, tissue transplantation, and alternative technologies are included. The report provides information on company placement within the market and strategic analyses of the companies' available and emerging products.

An appendix featuring various terms and processes used in transplantation is provided at the end of the report.

This report cites autologous products only in relation to their impact on the market for allografts. It does not include blood products, except for peripheral and umbilical cord blood as a source of stem cells.

By geography, the market has been segmented into the North America, Europe, Asia-Pacific, and Rest of the World regions. Detailed analysis of the market in major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2024.

Report Includes:

  • 26 data tables and 37 additional tables
  • An overview of the global organ and tissue transplantation and alternatives market
  • Estimation of the market size and analyses of market trends, with data from 2018 to 2019, estimates for 2020 and projection of CAGR through 2024
  • Details about organ and tissue transplantation and alternatives, their pathophysiology and affects, and major advancement and latest trends
  • A look at the regulatory scenarios and initiatives by government organization
  • Analysis of current and future market dynamics and identification of key drivers, restraints and opportunities such as increasing incidence of organ donations, improved awareness about organ donations, side effects of organ and tissue transplantation and antibiotic resistance infections
  • Coverage of emerging procedures and products in development and discussion on prevalence of major chronic diseases which initiates organ damage or donation
  • Discussion on the role of the organ procurement organization and information on transplantation process and preparation and coverage of issues like black market donors
  • Impact analysis of COVID-19 on organ and tissue transplantation and alternatives market
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players of the industry, including Abiomed Inc., Bayer AG, F. Hoffmann-La Roche & Co., Johnson & Johnson, Novartis AG, Pfizer Inc. and XVIVO Perfusion

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Cost of Care
  • Solid Organ Preservation
  • Immunosuppression
  • Organ Transplantation Alternatives
  • Trends in Organ and Tissue Transplantation Techniques and Their Alternatives
  • 3D Tissue Assembly
  • Nanotechnology for Tissue Regeneration
  • Innovation by Small Firms

Chapter 4 Market Dynamics

  • Market Drivers
  • Increasing Epidemiology of Different Diseases Influencing Organ Transplantations
  • Rise in the Geriatric Population
  • Rising Awareness of Importance of Organ and Tissue Donation
  • New Therapeutic Pathways for Organ Transplantation and Their Alternatives
  • Market Restraints
  • Challenges in Human Leukocyte Antigen (HLA) Sequencing
  • Demand and Supply Gap
  • Market Opportunities
  • Growing Economic Benefits of Organ and Tissue Transplants
  • Improvement in Healthcare Infrastructure

Chapter 5 Market Breakdown by Product & Devices

  • Global Market for Organ and Tissue Transplantation and Alternatives
  • Alternative Technologies
  • Market Size and Forecast
  • Alternatives to Heart Transplantation
  • Surgical
  • Mechanical
  • Total Artificial Heart
  • Ventricular Assist Devices (VADs)
  • Generations of Designs
  • Orthopedic Alternatives
  • Tissue Products
  • Market Size and Forecast
  • Immunosuppressants
  • Market Size and Forecast
  • Solid Organ Preservation Solutions
  • Market Size and Forecast
  • Preservation Solutions in Development
  • Tissue Typing
  • Market Size and Forecast

Chapter 6 Market Breakdown by Region

  • Global Market for Organ and Tissue Transplantation and Alternatives by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia and New Zealand
  • Rest of Asia-Pacific
  • Rest of the World
  • Market Analysis
  • Brazil
  • South Africa
  • Rest of the World Countries

Chapter 7 Impact of COVID-19

  • Introduction
  • Impact on Kidney Transplant Program
  • Impact on Pharmaceutical Companies
  • Donor Testing
  • COVID-19 in Transplant Recipients
  • Minimizing Infection Risk in Recipients
  • Future Perspectives

Chapter 8 Overview of Donation Process

  • Introduction
  • Black Market Donors
  • The Transplantation Process
  • Cost of Solid Organ Transplantation in the U.S.

Chapter 9 Regulations & Reimbursement

  • Regulations in the U.S.
  • U.S. Federal Regulation of Human Tissue
  • History of Regulation in the U.S.
  • Regulations Outside the U.S.
  • Reimbursement in the U.S.
  • Organ Acquisition Costs
  • Reimbursement for Hospital Costs
  • Reimbursement for Physician Services
  • Reimbursement for Immunosuppressants in the U.S.
  • Reimbursement Outside the U.S.
  • Treatment in EU Countries

Chapter 10 Competitive Landscape

  • Global Company Ranking Analysis
  • Mergers and Acquisitions
  • Agreements, Launches, Collaborations, and Partnerships

Chapter 11 Company Profiles

  • ABIOMED INC.
  • ABBVIE INC.
  • AMGEN INC.
  • ASTRAZENECA
  • BAYER AG
  • BRISTOL-MYERS SQUIBB
  • CAREDX INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • JOHNSON & JOHNSON
  • MYLAN N.V.
  • NOVARTIS AG
  • PFIZER INC.
  • TRANSMEDICS INC.
  • VERTEX PHARMACEUTICALS INC.
  • XVIVO PERFUSION

Chapter 12 Appendix: Acronyms